feed,title,long_url,short_url
SeekingAlpha,The 60/40 Portfolio: Regaining Its Appeal,https://seekingalpha.com/article/4624614,
SeekingAlpha,DiaMedica Therapeutics: Risk-Reward Favors Following Insider Optimism,https://seekingalpha.com/article/4624596,
